介入放射治疗后造影剂相关急性肾损伤的发生率、危险因素和结局:一项系统回顾和荟萃分析

IF 4
Frontiers in radiology Pub Date : 2026-09-23 eCollection Date: 2026-01-01 DOI:10.3389/fradi.2026.1947256
Saad Alhumaid, Mohammed Yousef Almulhim, Hessah Abdulaziz Al Hussaini, Qasem M Alalwan, Hani Almohammed Ali, Sarah A Al Ruzaihan, Fatima A Aborshaid, Abdulrhman Khaled Al Abdulqader, Nourah Al Dossary, Muneera Alabdulqader, Shaden Saleh AlMousa, Khalid Suliman Aljoqiman
{"title":"介入放射治疗后造影剂相关急性肾损伤的发生率、危险因素和结局:一项系统回顾和荟萃分析","authors":"Saad Alhumaid, Mohammed Yousef Almulhim, Hessah Abdulaziz Al Hussaini, Qasem M Alalwan, Hani Almohammed Ali, Sarah A Al Ruzaihan, Fatima A Aborshaid, Abdulrhman Khaled Al Abdulqader, Nourah Al Dossary, Muneera Alabdulqader, Shaden Saleh AlMousa, Khalid Suliman Aljoqiman","doi":"10.3389/fradi.2026.1947256","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Contrast-associated acute kidney injury (CA-AKI) is a recognized complication of iodinated contrast administration. Although extensively studied in coronary angiography, its incidence, associated factors, and outcomes following interventional radiology and other non-coronary endovascular procedures remain incompletely characterized. We evaluated the incidence, associated factors, and outcomes of CA-AKI in these populations.</p><p><strong>Methods: </strong>This systematic review followed PRISMA 2020 guidelines and a prospectively registered PROSPERO protocol (CRD420261385592). PubMed/MEDLINE, Embase, Scopus, CINAHL, and Web of Science were searched from inception to 30 April 2026. Eligible studies evaluated CA-AKI following catheter-based non-coronary endovascular or interventional radiology procedures. Random-effects meta-analysis estimated pooled incidence, with subgroup and sensitivity analyses.</p><p><strong>Results: </strong>Thirty-nine studies were included, of which 38 contributed to the meta-analysis. The pooled CA-AKI incidence was 6.91% (95% CI 5.69-8.24; I<sup>2</sup> = 89.5%). In a sensitivity analysis restricted to patient-level estimates (30 studies; 16,825 unique patients), incidence was 7.27% (95% CI 5.77-8.92; I<sup>2</sup> = 91.5%). Leave-one-out estimates ranged from 6.56% to 7.16%, indicating numerical stability despite substantial heterogeneity. Exploratory subgroup analysis showed higher pooled incidence following embolization/interventional oncology than neuroendovascular/carotid procedures (8.44% vs. 5.48%; <i>p</i> = 0.0171), although substantial residual heterogeneity renders this finding hypothesis-generating. Frequently reported associated factors included baseline renal dysfunction, advanced liver disease, diabetes mellitus, anaemia, hypoalbuminaemia, inflammatory burden, and greater contrast exposure. Heterogeneous observational evidence did not establish a clinically reliable contrast-volume threshold. Across individual studies, CA-AKI was associated with increased mortality, poorer functional outcomes, prolonged hospitalisation, and persistent renal dysfunction, although associations were not consistent across all studies and outcomes.</p><p><strong>Conclusion: </strong>CA-AKI occurs after a range of non-coronary endovascular and interventional radiology procedures and may be associated with clinically important adverse outcomes. Substantial heterogeneity limits the generalizability of a single pooled incidence estimate, and procedure- and population-specific estimates should remain central to interpretation. Standardised definitions and prospective multicentre studies are needed to establish procedure-specific risk profiles and clinically useful preventive strategies.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/view/CRD420261385592, PROSPERO, CRD420261385592.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":"6 ","pages":"1947256"},"PeriodicalIF":4.0000,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642721/pdf/","citationCount":"0","resultStr":"{\"title\":\"Incidence, risk factors, and outcomes of contrast-associated acute kidney injury following interventional radiology procedures: a systematic review and meta-analysis.\",\"authors\":\"Saad Alhumaid, Mohammed Yousef Almulhim, Hessah Abdulaziz Al Hussaini, Qasem M Alalwan, Hani Almohammed Ali, Sarah A Al Ruzaihan, Fatima A Aborshaid, Abdulrhman Khaled Al Abdulqader, Nourah Al Dossary, Muneera Alabdulqader, Shaden Saleh AlMousa, Khalid Suliman Aljoqiman\",\"doi\":\"10.3389/fradi.2026.1947256\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Contrast-associated acute kidney injury (CA-AKI) is a recognized complication of iodinated contrast administration. Although extensively studied in coronary angiography, its incidence, associated factors, and outcomes following interventional radiology and other non-coronary endovascular procedures remain incompletely characterized. We evaluated the incidence, associated factors, and outcomes of CA-AKI in these populations.</p><p><strong>Methods: </strong>This systematic review followed PRISMA 2020 guidelines and a prospectively registered PROSPERO protocol (CRD420261385592). PubMed/MEDLINE, Embase, Scopus, CINAHL, and Web of Science were searched from inception to 30 April 2026. Eligible studies evaluated CA-AKI following catheter-based non-coronary endovascular or interventional radiology procedures. Random-effects meta-analysis estimated pooled incidence, with subgroup and sensitivity analyses.</p><p><strong>Results: </strong>Thirty-nine studies were included, of which 38 contributed to the meta-analysis. The pooled CA-AKI incidence was 6.91% (95% CI 5.69-8.24; I<sup>2</sup> = 89.5%). In a sensitivity analysis restricted to patient-level estimates (30 studies; 16,825 unique patients), incidence was 7.27% (95% CI 5.77-8.92; I<sup>2</sup> = 91.5%). Leave-one-out estimates ranged from 6.56% to 7.16%, indicating numerical stability despite substantial heterogeneity. Exploratory subgroup analysis showed higher pooled incidence following embolization/interventional oncology than neuroendovascular/carotid procedures (8.44% vs. 5.48%; <i>p</i> = 0.0171), although substantial residual heterogeneity renders this finding hypothesis-generating. Frequently reported associated factors included baseline renal dysfunction, advanced liver disease, diabetes mellitus, anaemia, hypoalbuminaemia, inflammatory burden, and greater contrast exposure. Heterogeneous observational evidence did not establish a clinically reliable contrast-volume threshold. Across individual studies, CA-AKI was associated with increased mortality, poorer functional outcomes, prolonged hospitalisation, and persistent renal dysfunction, although associations were not consistent across all studies and outcomes.</p><p><strong>Conclusion: </strong>CA-AKI occurs after a range of non-coronary endovascular and interventional radiology procedures and may be associated with clinically important adverse outcomes. Substantial heterogeneity limits the generalizability of a single pooled incidence estimate, and procedure- and population-specific estimates should remain central to interpretation. Standardised definitions and prospective multicentre studies are needed to establish procedure-specific risk profiles and clinically useful preventive strategies.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/view/CRD420261385592, PROSPERO, CRD420261385592.</p>\",\"PeriodicalId\":73101,\"journal\":{\"name\":\"Frontiers in radiology\",\"volume\":\"6 \",\"pages\":\"1947256\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2026-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642721/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fradi.2026.1947256\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fradi.2026.1947256","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Incidence, risk factors, and outcomes of contrast-associated acute kidney injury following interventional radiology procedures: a systematic review and meta-analysis.

Background: Contrast-associated acute kidney injury (CA-AKI) is a recognized complication of iodinated contrast administration. Although extensively studied in coronary angiography, its incidence, associated factors, and outcomes following interventional radiology and other non-coronary endovascular procedures remain incompletely characterized. We evaluated the incidence, associated factors, and outcomes of CA-AKI in these populations.

Methods: This systematic review followed PRISMA 2020 guidelines and a prospectively registered PROSPERO protocol (CRD420261385592). PubMed/MEDLINE, Embase, Scopus, CINAHL, and Web of Science were searched from inception to 30 April 2026. Eligible studies evaluated CA-AKI following catheter-based non-coronary endovascular or interventional radiology procedures. Random-effects meta-analysis estimated pooled incidence, with subgroup and sensitivity analyses.

Results: Thirty-nine studies were included, of which 38 contributed to the meta-analysis. The pooled CA-AKI incidence was 6.91% (95% CI 5.69-8.24; I2 = 89.5%). In a sensitivity analysis restricted to patient-level estimates (30 studies; 16,825 unique patients), incidence was 7.27% (95% CI 5.77-8.92; I2 = 91.5%). Leave-one-out estimates ranged from 6.56% to 7.16%, indicating numerical stability despite substantial heterogeneity. Exploratory subgroup analysis showed higher pooled incidence following embolization/interventional oncology than neuroendovascular/carotid procedures (8.44% vs. 5.48%; p = 0.0171), although substantial residual heterogeneity renders this finding hypothesis-generating. Frequently reported associated factors included baseline renal dysfunction, advanced liver disease, diabetes mellitus, anaemia, hypoalbuminaemia, inflammatory burden, and greater contrast exposure. Heterogeneous observational evidence did not establish a clinically reliable contrast-volume threshold. Across individual studies, CA-AKI was associated with increased mortality, poorer functional outcomes, prolonged hospitalisation, and persistent renal dysfunction, although associations were not consistent across all studies and outcomes.

Conclusion: CA-AKI occurs after a range of non-coronary endovascular and interventional radiology procedures and may be associated with clinically important adverse outcomes. Substantial heterogeneity limits the generalizability of a single pooled incidence estimate, and procedure- and population-specific estimates should remain central to interpretation. Standardised definitions and prospective multicentre studies are needed to establish procedure-specific risk profiles and clinically useful preventive strategies.

Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261385592, PROSPERO, CRD420261385592.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书